Purchase Order 75F40126P00050

<p>The Food and Drug Administration issued a delivery order to the National Academy of Sciences on June 1, 2026, with a ceiling value of $1,116,650.54 under a cost-no-fee pricing structure for a Substandard and Falsified Medical Products Workshop.</p> <p>Place of performance is Berwyn Heights, MD 20740. The order extends through May 31, 2031. No set-aside applies to this delivery order.</p>

The Food and Drug Administration awarded a firm fixed-price purchase order to Association For The Advancement Of Medical Instrumentation, Inc. for $606,985 on September 9, 2025, to support quality and compliance training for the Center for Devices and Radiological Health. Performance occurs in Silver Spring, Maryland, with an ultimate completion date of September 9, 2028. The order carries no set-aside designation. AAMI, a nonprofit standards and professional education organization, will deliver...

The Department of Health and Human Services Food and Drug Administration awarded a $145,636.17 firm fixed price delivery order to We Pharma, Inc. of Silver Spring, Maryland for pharmaceutical products to support domestic manufacturing. No set-aside provisions were applied to this contract. We Pharma will provide the FDA's Office of Pharmaceutical Quality with domestic pharmaceutical manufacturing supplies through September 30th, 2022 at their Silver Spring location. As the regulatory body...

The Food and Drug Administration (FDA) awarded a $4.46M firm fixed-price delivery order to IQVIA Government Solutions Inc. for hospital inpatient and emergency department drug utilization data services. This delivery order, which is not set-aside designated, runs through August 22, 2030, and will be performed in Silver Spring, Maryland. The contract supports the FDA's post-market drug safety surveillance and regulatory decision-making capabilities by providing comprehensive, HIPAA-compliant...

The Food and Drug Administration issued a delivery order to Data Quality Science, LLC on September 23, 2025, with a ceiling value of $186,106.67, under a total small business set-aside. The order is issued under the FDA's Region 4 IDIQ for tobacco retailer compliance inspection services, a $35 million total small business set-aside indefinite delivery contract awarded September 24, 2021, with an ultimate completion date of September 29, 2026. Place of performance is Baltimore, MD. The delivery...

The Food and Drug Administration (FDA) awarded a delivery order to Dun &amp; Bradstreet, Inc., doing business as Dun &amp; Bradstreet Receivable Management Services, on September 17, 2025, with a ceiling value of $181,496.70. This firm fixed-price delivery order requires the contractor to research, analyze, and maintain the SRO (Special Review Officer) List on a monthly basis through September 21, 2026, with an option exercisable through September 21, 2026. The contract was awarded without...

The Food and Drug Administration issued a delivery order to International Business Machines Corporation on September 10, 2025, with a ceiling value of $1,126,329.48 under the GSA Multiple Award Schedule (MAS) to provide a centralized hub for information, resources, training, and analytical support assisting CDER reviewers in using OCS tools and services. Place of performance is Takoma Park, MD. The order is firm fixed price with an ultimate completion date of September 16, 2026. The...

<p>The Food and Drug Administration issued a purchase order to Agilent Technologies Inc. for Genomics Information Management System (GIMS) and customization valued at $42,993.00, awarded September 29, 2022, with an ultimate completion date of August 19, 2023. Work is performed in Silver Spring, Maryland. The order is firm fixed price with no set-aside applied.</p>

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) on July 3, 2025. The order, valued at $3,458.51, is for the delivery of pharmaceutical products to support the DLA's medical supply chain. The order has an ultimate completion date of July 7, 2025. DMS Pharmaceutical Group Inc. is a long-standing vendor in the federal pharmaceutical supply chain, holding a significant single-award Indefinite...

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order valued at $21,296.08 from the Defense Logistics Agency's Medical Supply Chain division on August 6, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a discrete pharmaceutical supply requirement with an ultimate completion date of August 7, 2025. The delivery order falls under DMS Pharmaceutical Group's larger...